Richard Klausner
CIK 1591178 · Executive Chairman · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$55.13M
Companies
4
Total Filings
47
Lifetime Open-Market Net
-$11.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBLS | Director | — | — | — | $0 | 1 | 2026-06-11 |
| LYEL | Director | 3,811,199 | $13.50 | $51.45M | -$108.4K | 9 | 2025-05-19 |
| Juno Therapeutics, Inc. (JUNO) Delisted | Director | 0 | — | — | -$10.49M | 27 | 2018-03-07 |
| ILMN | Sr VP, Chief Medical Officer | 22,847 | $160.97 | $3.68M | -$420.0K | 10 | 2016-02-01 |
Recent Filings · Page 4 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-01 | ILMN | Tax (F) | −253 | -$40.0K | EDGAR |
| 2015-12-17 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −12,000 | -$548.6K | EDGAR |
| 2015-11-16 | ILMN | Sell (S) | −730 | -$119.4K | EDGAR |
| 2015-11-13 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −12,000 | -$594.1K | EDGAR |
| 2015-11-06 | ILMN | Tax (F) | −186 | -$28.8K | EDGAR |
| 2015-10-16 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −8,000 | -$400.0K | EDGAR |
| 2015-10-13 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −16,000 | -$800.0K | EDGAR |
| 2015-09-29 | ILMN | Sell (S) | −423 | -$73.3K | EDGAR |
| 2015-09-25 | ILMN | Tax (F) | −509 | -$96.7K | EDGAR |
| 2015-07-17 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −8,000 | -$426.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.